Alzheimer’s | Neuline

Parkinson’s, How it Differs from Alzheimer’s, Biomarkers, and the Major Challenges the Community Face

Since the discovery of dopamine as a neurotransmitter in the 1950s, Parkinson’s disease (PD) research has generated a rich and complex body of knowledge, revealing PD to be an age-related multifactorial disease, influenced by both genetic and environmental factors. The tremendous complexity of the disease is increased by a nonlinear progression of the pathogenesis between molecular, cellular and organic systems.

Missed appointments aren’t just missed appointments: They’re missed opportunities for early detection

There are perfectly reasonable explanations for why people are missing or canceling appointments, but these canceled appointments aren’t just missed appointments: they’re missed opportunities to detect conditions where there is an understanding that early detection can help patients maintain a higher quality of life for a longer period of time.

Four Types of EEGs

EEGs – or electroencephalograms – are used to diagnose many neurological conditions. Depending on the condition, your health care provider may order one of four different types of EEGs.

How Does Alzheimer’s Disease Affect the Brain?

While research surrounding prevention and treatment of Alzheimer’s is ongoing, scientists know the disease involves complex changes in the brain. Learn more:

Is Alzheimer’s Disease A Women’s Health Problem?

For decades, part of the high risk factor for women was attributed to longevity, as women statistically live 4-6 years longer than men and age is the greatest risk factor for Alzheimer’s. Recent studies have identified additional risk factors that continue to place women at a higher risk for the disease:

What’s the difference between dementia and Alzheimer’s disease?

Dementia and Alzheimer’s disease both affect cognitive and memory functions of the brain. Alzheimer’s disease is a specific type of dementia.

Next Entries »